Pathologic Complete Response After Neoadjuvant Chemoradiation in a Patient with Gastric Neuroendocrine Cancer
Authors:
Open Access
- 23 July 2019
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 11 (7) , e5214
Abstract
Neuroendocrine tumors are about 0.5% of all malignancies. Specifically, for gastrointestinal (GI) malignancies, neuroendocrine tumor incidence is approximately 1%-2% per year. Gastric neuroendocrine neoplasms are rare and consist of various tumor types with differing histomorphology, pathogenesis, and biological behavior. Following surgery, post-operative chemotherapy is generally considered the standard of care. Our case report demonstrates the potential benefit of neoadjuvant concurrent chemoradiotherapy prior to surgery for a malignant gastric neuroendocrine tumor. While radiotherapy has been demonstrated to possibly provide a survival benefit in the treatment of GI neuroendocrine tumors, its use in treatment, particularly neoadjuvantly, needs to be further assessed.Keywords
This publication has 18 references indexed in Scilit:
- Small cell carcinoma of the stomach: A report of two cases and a review of the literatureMolecular and Clinical Oncology, 2018
- Neuroendocrine carcinoma of the gastric stump: A case report and literature reviewWorld Journal of Gastroenterology, 2018
- Giant type III well-differentiated neuroendocrine tumor of the stomach: A case reportInternational Journal of Surgery Case Reports, 2016
- Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumorsAnnals of Diagnostic Pathology, 2015
- Management of primary gastric small cell carcinoma in China.2015
- Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature reviewWorld Journal of Gastroenterology, 2015
- Diagnosis and treatment of gastric neuroendocrine tumoursWiener klinische Wochenschrift, 2007
- Small-Cell Carcinomas of the Gastrointestinal Tract: A ReviewJournal of Clinical Oncology, 2004
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999
- Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung CancerAnnals of Internal Medicine, 1987